EVANSVILLE, Ind. (WFIE) - An Evansville primary doctor became one of the first people in the world to get treated for COVID-19 with Eli Lilly’s monoclonal antibodies.
Dr. David Shultz is the principal investigator of the project.
The monoclonal antibody that Dr. Shultz received is called bamlanivimab.
It’s currently being produced and distributed across the world.
“Clark Memorial in Jeffersonville, Indiana - they were able to get me in there and get the monoclonal antibody yesterday," Dr. Schultz said. "Compared to yesterday, I’m feeling much better. I still lack a little bit of energy, but the amounts of fatigue, body aches, nausea and even my sense of smell is beginning to improve a little bit.”
He says the treatment binds to the spike proteins at the end of the virus, which decreases the amount of replication the virus can undergo. This method makes for a faster and more efficient recovery from coronavirus.
Dr. Shultz says that clinical trials reveal mild symptoms from the treatment.
He also urges people to wear their masks, especially with the holidays quickly approaching.
For anybody who begins to feel sick, Dr. Shultz says to not hesitate and get tested for COVID-19.